Julia A Mattson, MD | |
1602 Angleside Rd, Fallston, MD 21047-1744 | |
(410) 652-8310 | |
Not Available |
Full Name | Julia A Mattson |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 1602 Angleside Rd, Fallston, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285603241 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | D0063050 (Maryland) | Primary |
Entity Name | Christiana Care Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770568107 PECOS PAC ID: 9739097569 Enrollment ID: O20031201000477 |
News Archive
U.S. News & World Report has released its 23rd annual Best Hospitals rankings and a new hospital has seized the No. 1 spot.
Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it. Now, researchers at UCLA's Jonsson Comprehensive Cancer Center have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene.
The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacteria cause millions of localized infections, but more serious, systemic blood infections are rare.
American Civil Liberties Union on behalf of the Sexuality Information and Education Council of the United States and Advocates for Youth on Thursday sent a letter to HHS Secretary Mike Leavitt saying that the agency should enforce a federal law that states abstinence education must include "medically accurate" information about condom effectiveness, the Washington Times reports (Wetzstein, Washington Times , 4/27).
Mimetogen Pharmaceuticals Inc. today announced positive top line data from the Phase II clinical trial of MIM-D3 for dry eye disease. The trial demonstrated statistically significant improvements in signs and symptoms with its low (1%) and high (5%) doses of MIM-D3, together with excellent safety and tolerability profiles.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Julia A Mattson, MD 1602 Angleside Rd, Fallston, MD 21047-1744 Ph: (410) 652-8310 | Julia A Mattson, MD 1602 Angleside Rd, Fallston, MD 21047-1744 Ph: (410) 652-8310 |
News Archive
U.S. News & World Report has released its 23rd annual Best Hospitals rankings and a new hospital has seized the No. 1 spot.
Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it. Now, researchers at UCLA's Jonsson Comprehensive Cancer Center have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene.
The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacteria cause millions of localized infections, but more serious, systemic blood infections are rare.
American Civil Liberties Union on behalf of the Sexuality Information and Education Council of the United States and Advocates for Youth on Thursday sent a letter to HHS Secretary Mike Leavitt saying that the agency should enforce a federal law that states abstinence education must include "medically accurate" information about condom effectiveness, the Washington Times reports (Wetzstein, Washington Times , 4/27).
Mimetogen Pharmaceuticals Inc. today announced positive top line data from the Phase II clinical trial of MIM-D3 for dry eye disease. The trial demonstrated statistically significant improvements in signs and symptoms with its low (1%) and high (5%) doses of MIM-D3, together with excellent safety and tolerability profiles.
› Verified 2 days ago